Nichols & Pratt Advisers LLP MA Trims Holdings in CIGNA Co. (CI)

Share on StockTwits

Nichols & Pratt Advisers LLP MA trimmed its holdings in shares of CIGNA Co. (NYSE:CI) by 9.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,350 shares of the health services provider’s stock after selling 800 shares during the quarter. Nichols & Pratt Advisers LLP MA’s holdings in CIGNA were worth $1,531,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Los Angeles Capital Management & Equity Research Inc. grew its holdings in CIGNA by 1.8% during the 3rd quarter. Los Angeles Capital Management & Equity Research Inc. now owns 70,300 shares of the health services provider’s stock worth $14,640,000 after acquiring an additional 1,270 shares during the last quarter. Gulf International Bank UK Ltd lifted its position in shares of CIGNA by 5.0% in the 3rd quarter. Gulf International Bank UK Ltd now owns 81,929 shares of the health services provider’s stock worth $17,061,000 after purchasing an additional 3,880 shares during the period. BP PLC lifted its position in shares of CIGNA by 13.5% in the 3rd quarter. BP PLC now owns 29,500 shares of the health services provider’s stock worth $6,143,000 after purchasing an additional 3,500 shares during the period. WINTON GROUP Ltd lifted its position in shares of CIGNA by 14.8% in the 3rd quarter. WINTON GROUP Ltd now owns 214,826 shares of the health services provider’s stock worth $44,738,000 after purchasing an additional 27,675 shares during the period. Finally, GABELLI & Co INVESTMENT ADVISERS INC. acquired a new position in shares of CIGNA in the 3rd quarter worth approximately $1,145,000. 89.11% of the stock is currently owned by hedge funds and other institutional investors.

CIGNA stock opened at $214.24 on Wednesday. The company has a debt-to-equity ratio of 1.61, a quick ratio of 0.98 and a current ratio of 0.98. CIGNA Co. has a 12-month low of $163.02 and a 12-month high of $227.13. The firm has a market cap of $51.87 billion, a P/E ratio of 20.48, a P/E/G ratio of 1.22 and a beta of 0.58.

CIGNA (NYSE:CI) last released its earnings results on Thursday, November 1st. The health services provider reported $3.84 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $3.45 by $0.39. CIGNA had a net margin of 6.15% and a return on equity of 23.31%. The company had revenue of $11.45 billion for the quarter, compared to the consensus estimate of $11.19 billion. During the same quarter in the previous year, the company earned $2.83 EPS. CIGNA’s quarterly revenue was up 10.3% compared to the same quarter last year. On average, equities research analysts expect that CIGNA Co. will post 14.35 EPS for the current fiscal year.

In other CIGNA news, Director William D. Zollars sold 238 shares of the company’s stock in a transaction on Friday, September 14th. The shares were sold at an average price of $193.70, for a total transaction of $46,100.60. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Jason D. Sadler sold 21,189 shares of the company’s stock in a transaction on Friday, November 2nd. The stock was sold at an average price of $212.99, for a total transaction of $4,513,045.11. Following the transaction, the insider now owns 41,966 shares in the company, valued at approximately $8,938,338.34. The disclosure for this sale can be found here. 1.10% of the stock is owned by insiders.

CI has been the topic of a number of recent analyst reports. ValuEngine upgraded shares of CIGNA from a “sell” rating to a “hold” rating in a research report on Friday, August 3rd. BMO Capital Markets boosted their price target on shares of CIGNA from $220.00 to $230.00 and gave the stock a “hold” rating in a research report on Friday, November 2nd. Jefferies Financial Group restated a “buy” rating and issued a $224.00 price target on shares of CIGNA in a research report on Friday, August 3rd. SunTrust Banks boosted their price target on shares of CIGNA to $244.00 and gave the stock a “buy” rating in a research report on Friday, August 3rd. Finally, Citigroup boosted their price target on shares of CIGNA from $243.00 to $249.00 and gave the stock a “buy” rating in a research report on Friday, November 2nd. Four analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $233.14.

TRADEMARK VIOLATION WARNING: “Nichols & Pratt Advisers LLP MA Trims Holdings in CIGNA Co. (CI)” was reported by Week Herald and is the property of of Week Herald. If you are accessing this story on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright laws. The legal version of this story can be read at https://weekherald.com/2018/11/07/nichols-pratt-advisers-llp-ma-trims-holdings-in-cigna-co-ci.html.

CIGNA Company Profile

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers.

Recommended Story: Consumer behavior in bull markets

Institutional Ownership by Quarter for CIGNA (NYSE:CI)

Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply